Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000186954
Ethics application status
Approved
Date submitted
9/02/2020
Date registered
19/02/2020
Date last updated
13/04/2021
Date data sharing statement initially provided
19/02/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
Attitudes towards virtual reality for use in skin cancer prevention in healthy adults
Scientific title
Attitudes towards virtual reality for use in skin cancer prevention in healthy adults - a qualitative study
Secondary ID [1] 300486 0
nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
skin cancer 316158 0
sun exposure 316159 0
sunburn 316160 0
Condition category
Condition code
Public Health 314454 314454 0 0
Health promotion/education
Cancer 314455 314455 0 0
Malignant melanoma
Cancer 314456 314456 0 0
Non melanoma skin cancer
Injuries and Accidents 314457 314457 0 0
Burns

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
This is an exploratory qualitative study on patient attitudes towards use of virtual reality technologies in skin cancer prevention.

A series of focus groups will be conducted, with each participant to only attend one focus group. Participants will be asked to complete a demographic survey at the beginning of the focus group. The facilitator will follow a semi-structured format and follow the discussion guide. Participants provide verbal feedback during the focus group. Topics in the discussion guide include current sun protection practices, and participants will be introduced to the virtual reality technology. During the focus group participants will be asked to undertake a virtual reality experience using the provided virtual reality headset (lasts for 5-7 minutes). Participants will then be asked to provide verbal feedback on their experience. The virtual reality experience will explore virtual worlds including elements of the human body as well as movement based activities. Participants remain seated during the virtual reality experience.

The assistant facilitator will audio record the focus group and takes notes. Each focus group will last 45 minutes and be held at the Institute of Health and Biomedical Innovation, Kelvin Grove, Brisbane.
Intervention code [1] 316795 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 322790 0
satisfaction with the virtual reality experience as assessed by thematic analysis of recorded focus group
Timepoint [1] 322790 0
One-off focus group
Secondary outcome [1] 379778 0
nil
Timepoint [1] 379778 0
nil

Eligibility
Key inclusion criteria
aged 18 years of age and over and understand sufficient English to provide informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
You are ineligible if you are pregnant or have pre-existing conditions that may affect your virtual reality experience such as vision abnormalities, psychiatric disorders, suffer from a seizure disorder, heart conditions or other serious health conditions. Implanted medical devices such as cardiac pacemakers, hearing aids & defibrillators can be affected by virtual reality components magnetic field and are therefore excluded from this study.

You should not use the VR products if you are tired, need sleep, are under the influence of alcohol or drugs, are hung-over, have digestive problems, are under emotional stress or anxiety, or when suffering from cold, flu, headaches, migraines, or earaches, as this can increase your susceptibility to adverse effects.

Study design
Purpose
Duration
Cross-sectional
Selection
Convenience sample
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
13/04/2020
Actual
25/08/2020
Date of last participant enrolment
Anticipated
4/05/2020
Actual
6/09/2020
Date of last data collection
Anticipated
4/05/2020
Actual
15/09/2020
Sample size
Target
20
Accrual to date
Final
18
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 304905 0
University
Name [1] 304905 0
Queensland University of Technology
Country [1] 304905 0
Australia
Primary sponsor type
University
Name
Queensland University of Technology
Address
60 Musk Ave, Kelvin Grove, Brisbane, Queensland, 4059
Country
Australia
Secondary sponsor category [1] 305247 0
None
Name [1] 305247 0
Address [1] 305247 0
Country [1] 305247 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305314 0
Queensland University of Technology University Human Research Ethics Committee [EC00171]
Ethics committee address [1] 305314 0
Ethics committee country [1] 305314 0
Australia
Date submitted for ethics approval [1] 305314 0
Approval date [1] 305314 0
31/01/2020
Ethics approval number [1] 305314 0
1900001157

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 99962 0
Dr Elke Hacker
Address 99962 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 99962 0
Australia
Phone 99962 0
+61 7 3138 9674
Fax 99962 0
Email 99962 0
[email protected]
Contact person for public queries
Name 99963 0
Elke Hacker
Address 99963 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 99963 0
Australia
Phone 99963 0
+61 7 3138 9674
Fax 99963 0
Email 99963 0
[email protected]
Contact person for scientific queries
Name 99964 0
Elke Hacker
Address 99964 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 99964 0
Australia
Phone 99964 0
+61 7 3138 9674
Fax 99964 0
Email 99964 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.